Fact CheckerSign in

NCT06566313Completed

An Open-label Study on the Clinical Efficacy of tDCS Intervention in PD

Source: ClinicalTrials.gov · Last updated 18 Dec 2024

Brief summary (registry, in English)

To demonstrate that intervention targeting the primary motor area (M1) using transcranial Direct Current Stimulation can improve sleep symptoms in patients with Parkinson's disease.

Status (registry)
Completed
Study type
Interventional
Enrollment
17 (actual)
First submitted
20 Aug 2024
Start date
1 Jan 2021
Primary completion date
31 Dec 2022
Lead sponsor
Anhui Medical University
NCT number
NCT06566313

What you commit to

  • Study type: Interventional
  • Participants enrolled: 17
  • From 1 Jan 2021 to the primary completion date, 31 Dec 2022
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • The presence of other serious mental illness (such as major depression, psychosis or obsessive-compulsive disorder, physical illness or a history of substance abuse);
  • Have a head injury, stroke or other neurological disorder;
  • The diagnosis of PD dementia is difficult to complete the assessment.

Other

  • The patient has a metal object or skull brace device or any similar metal object on the scalp;
  • Head tremor or limb shaking is so severe that it is difficult to calmly receive treatment;

Who the study is looking for

  • The diagnosis of PD was determined by neurologists with rich clinical work experience, and was in line with the diagnostic criteria for Parkinson's disease in China (2016 edition).
  • The total score of RBD Screening Questionnaire (RBDSQ) is ≥6 points.
  • All patients took the drug stably and had no history of drug adjustment within 2 months before treatment. The test was conducted 2 hours after taking the drug.
  • Good compatibility, with a certain degree of compliance;
  • Normal mental condition, able to cooperate with behavioral tests and transcranial electrical stimulation treatment;

Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Cognitive Neuropsychology Lab Anhui Medical University
Coordinator of this site? Confirm its status
HefeiChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.